Risk Factor of Sarcopenia After Gastrectomy in Elderly Patients With Gastric Cancer.
By: Hironori Iwasaki, Erina Haraguchi, Takafumi Ihashi, Hiroshi Yokomizo

Department of Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan hiwasaki0519@gmail.com.
2023-6-15; doi: 10.21873/anticanres.16612
Abstract

Background/aim

Sarcopenia is a progressive and generalized muscle disorder correlated with an increased risk of adverse outcomes, including falls, fractures, physical disability and mortality. Moreover, sarcopenia is associated with short- and long-term outcomes after surgery in patients with gastrointestinal malignancies. Additionally, severe skeletal muscle loss after surgery reduces quality of life. In this study, we analyzed the perioperative risk factors for skeletal muscle loss after gastrectomy in elderly patients undergoing radical gastrectomy for gastric cancer.

Patients

In this case-control study, we enrolled patients aged ≥75 years who underwent radical gastrectomy for gastric cancer between January 2014 and December 2020 at our Institution. The psoas muscle index was used to assess skeletal muscle mass. They were divided into two groups-muscle depletion (D group) and no depletion (ND group)-depending on the ratio of skeletal muscle loss before and after gastrectomy.

Results

The D and ND groups comprised 34 and 41 patients, respectively. Univariate analysis showed that open gastrectomy was a potential risk factor for postoperative skeletal muscle loss in elderly gastric cancer patients (p=0.017). In multiple logistic regression analysis using the following variables: sex, operation and approach, the D group had a significantly higher proportion of patients who underwent open surgery than the ND group (p=0.032).

Conclusion

Open gastrectomy is an independent risk factor for the progression of sarcopenia after gastrectomy in elderly patients with gastric cancer. Laparoscopic surgery is an eligible method for preserving skeletal muscle mass in elderly patients with gastric cancer.



Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

PMID:37648324






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements